Skip to main content
Premium Trial:

Request an Annual Quote

TGen, Startup Mexican Genomics Institute to Join Forces

NEW YORK, April 17 - The Translational Genomics Research Institute and a number of US-based universities yesterday met with Mexico's National Institute of Genomic Medicine in an attempt to create a "cooperative research initiative" 

 

The meeting, which was held at TGen's offices in Phoenix, focused on outlining both institutes' goals and programs, the groups said. Additional meetings will likely develop specific cooperative projects, especially research aimed at diabetes and cancer.

 

"By sharing expertise, we hope to make significant strides in addressing a number health issues faced by both countries while recognizing that from a genomic medicine standpoint, both populations are unique," TGen President Jeffrey Trent said in a statement.

 

Gerardo Jiménez-Sánchez, director of INMEGEN, wrote in this month's Science that "genomic medicine in Mexico needs to be based on the genetic structure and health demands of the Mexican population, rather than importing applications developed for other populations." INMEGEN is being set up in Cuernavaca. 
 
Also at the meeting were representatives from the Mayo Clinic, Arizona State University, and the University of Arizona.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.